Prospective study of nutritional support during pelvic irradiation

Journal Article · Wed Apr 01 00:00:00 EST 1981 · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

DOI:https://doi.org/10.1016/0360-3016(81)90141-3· OSTI ID:6483070

Kinsella, T J; Malcolm, A W; Bothe, A Jr; Valerio, D; Blackburn, G L

A prospective study of nutritional support during pelvic irradiation was carried out in 32 patients with a primary pelvic malignancy and prior weight loss. Both curative and palliative patients were eligible for the study. Seventeen patients were randomized to receive intravenous hyperalimentation (IVH) and fifteen patients served as controls who were maintained on their regular diet. Patients were stratified by percent body weight loss. Tolerance to therapy was assessed by evaluation of functional status and by using nutritional parameters of body weight change, change in serum protein levels, and response to delayed hypersensitivity skin tests. The curative IVH group tolerated therapy well by both functional and nutritional measurements. All curative IVH patients completed the planned radiation therapy without a treatment break and were fully active following treatment. Patients gained an average of 4.0 kg body weight during irradiation, which was significantly different from the curative control patients. They demonstrated a significant increase in serum transferrin reflecting an improvement in visceral protein. In addition, all showed a positive response to delayed hypersensitivity skin tests at the completion of irradiation. The palliative IVH patients often did poorly because of progression of disease and demonstrated only an elevation of serum transferrin during treatment. The results in the curative IVH group suggest a potential adjunctive role for intravenous hyperalimentation in the malnourished cancer patient undergoing pelvic irradiation. Clearly, further study of nutritional support during pelvic irradiation is needed using curative patients with a single tumor type and significant prior weight loss.

• Research Organization: Harvard Medical School, Boston, MA
• OSTI ID: 6483070
• Journal Information: Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 7:4
• Country of Publication: United States
• Language: English

Related Subjects

63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
62 RADIOLOGY AND NUCLEAR MEDICINE
NUTRITION
RADIOSENSITIVITY EFFECTS
RADIOTHERAPY
SIDE EFFECTS
COMPARATIVE EVALUATIONS
EVALUATION
EXTERNAL IRRADIATION
FEEDING
INTRAVENOUS INJECTION
NEOPLASMS
PATIENTS
PELVIS
PROTEINS
TRANSFERRIN
WEIGHT
BODY
BODY AREAS
DISEASES
GLOBULINS
GLOBULINS-BETA
INJECTION
INTAKE
IRRADIATION
MEDICINE
METALLOPROTEINS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
RADIOLOGY
THERAPY
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)